Do You Qualify for GLP-1 Weight Loss Medication? What Doctors Actually Check

Weight loss

If half your feed seems to be shrinking on Wegovy or Zepbound, you’ve probably caught yourself wondering the same thing everyone wonders. Would I even qualify?

Fair question. And the answer is more straightforward than the internet makes it look.

Most adults qualify for GLP-1 weight loss medication with a BMI of 30 or higher, or a BMI of 27 or higher plus at least one weight-related health condition like high blood pressure, high cholesterol, or sleep apnea. Those thresholds come straight from the FDA prescribing information for Wegovy and Zepbound.

But the number on a BMI chart is where the conversation starts, not where it ends. So we asked the physicians who make these calls every day what they actually look at before writing the prescription.

“If you’ve been trying to lose weight doing diet and exercise for at least six months and not really seeing any results, I think it’s worth it to talk to a professional and see what your options are,” says Dr. Christin Barry, an emergency medicine physician with over 10 years of experience who treats weight loss patients through DrHouse.

Here’s what that conversation looks like from the doctor’s side of the screen.

Key Takeaways

• You generally qualify for a GLP-1 with a BMI of 30 or higher, or a BMI of 27 to 29.9 plus at least one weight-related condition such as hypertension, high cholesterol, sleep apnea, or PCOS.
• Every GLP-1 is prescription-only. There is no legitimate way to get one without a licensed clinician reviewing your health history first.
• Some people should not take GLP-1s at all, including anyone with a personal or family history of medullary thyroid cancer or MEN2, a history of pancreatitis, or a current pregnancy.
• Telehealth doctors can prescribe GLP-1s. The criteria are identical to an in-person visit, baseline labs included.
• Qualifying medically and getting your insurance to cover the medication are two separate hurdles. Many plans set a higher bar than the FDA does.

First, a Quick Primer on What GLP-1s Actually Do

GLP-1 stands for glucagon-like peptide-1, a hormone your body already makes to regulate blood sugar and appetite. The medications mimic it. They slow digestion, quiet hunger signals, and help you feel full on less food.

The trial results are why everyone’s talking about them. Adults taking semaglutide (the ingredient in Wegovy) lost an average of about 15% of their body weight over 68 weeks in the STEP 1 trial. Tirzepatide (Zepbound) went further, with average losses of up to about 21% at the highest dose in SURMOUNT-1.

Big numbers. Which is exactly why the qualification criteria exist. Medication this effective needs to go to the people it’s actually built for.

Who Qualifies for GLP-1 Weight Loss Medication? The Short Answer

To qualify for a GLP-1 prescribed for weight loss, you need a BMI of 30 or above, or a BMI of 27 or above with at least one weight-related comorbidity, and no contraindications in your medical history. A licensed clinician confirms all of it after reviewing your history, your medications, and in most cases your lab work.

“The main criteria we’re first looking at is BMI,” Dr. Barry explains. “You definitely need to have a BMI at least in the overweight category. Obese for sure you qualify, but also taking into consideration any comorbidities that you have like high cholesterol, high blood pressure, sleep apnea, PCOS.”

Given that more than 40% of American adults meet the clinical definition of obesity, a lot of people asking whether they qualify already do. The evaluation exists to confirm the medication is safe and appropriate for you specifically. That’s a different question than whether your BMI clears a bar.

And these aren’t experimental drugs, for what it’s worth. “GLP-1s have actually been around for almost 30 years for diabetes specifically,” notes Dr. Ragan Brackett, a physician board-certified in both family medicine and obesity medicine. “So that’s why we do know it is a safe drug actually.”

What BMI Do You Need to Qualify for a GLP-1?

A BMI of 30 or higher qualifies on its own. A BMI between 27 and 29.9 qualifies if you also have at least one weight-related health condition. Below 27, GLP-1s generally aren’t prescribed for weight loss.

Your BMI	Category (WHO)	Do you qualify?
30 or higher	Obesity	Yes. BMI alone qualifies
27 to 29.9	Overweight	Yes, with at least one weight-related condition (hypertension, high cholesterol, type 2 diabetes, sleep apnea, PCOS)
25 to 26.9	Overweight	Generally no for the weight loss indication, but worth a physician conversation
Below 25	Normal range	No. GLP-1s aren’t appropriate for weight loss at this BMI

The Part Most Guides Skip: BMI Isn’t the Same Bar for Everyone

Here’s something you won’t find on most telehealth landing pages.

BMI cutoffs were built largely on data from White populations, and body fat distribution differs across ethnic groups. A large cohort study in The Lancet Diabetes & Endocrinology found that the diabetes risk a White adult faces at a BMI of 30 shows up in South Asian adults at a BMI as low as 23.9.

DrHouse’s clinical guidelines for GLP-1 prescribing account for this research directly. A one-size-fits-all cutoff can miss the patients at the highest metabolic risk.

It’s also why physicians get a little frustrated when BMI is treated as the whole story.

“You can see someone who has an abnormal BMI, but can be very healthy,” Dr. Brackett says. “You can also see people with normal BMIs… potentially unhealthy and might have cholesterol-filled arteries and be at risk for cardiovascular disease, like heart attack or stroke. I think we got to get away from using BMI sometimes.”

So think of the table above as telling you whether the conversation is worth having. The physician tells you whether the medication is right.

Which Health Conditions Count as Qualifying Comorbidities?

If your BMI falls between 27 and 29.9, you’ll need at least one weight-related health condition to qualify. The ones physicians and insurers most commonly accept: type 2 diabetes or prediabetes, high blood pressure, high cholesterol, obstructive sleep apnea, PCOS, fatty liver disease, and cardiovascular disease.

These aren’t arbitrary boxes. Each of these conditions tends to improve as weight comes down, which is a big part of the clinical case for treating them together. “Those also are all improved by starting these medications,” Dr. Barry notes.

Dr. Chandler, a family medicine physician who has practiced exclusively through telehealth for the past several years, tells his patients to watch those numbers as closely as the scale. “As I tell people, the numbers should get better, right? Your cholesterol should get better. Your blood pressure should get better. Diabetes numbers, your glucose all should get better.”

Not sure whether you actually have one of these conditions? That’s exactly what the lab work in your first evaluation is designed to find out. More on that in a minute.

Who Should NOT Take GLP-1s?

GLP-1 medications are not appropriate for people with a personal or family history of medullary thyroid carcinoma or MEN2 (Multiple Endocrine Neoplasia syndrome type 2), a history of pancreatitis, or anyone currently pregnant or breastfeeding. They’re also not meant for people at a normal or low body weight.

When Dr. Barry walks a new patient through their first visit, this screen comes before anything else. “We’ll review your medical history, your weight and height to calculate your BMI, any history of any of the contraindications to treatment such as medullary thyroid cancer, pancreatitis, such as that.”

Under DrHouse’s prescribing guidelines, pregnancy and breastfeeding are hard stops. Certain mental health conditions call for additional evaluation, with a referral to a mental health specialist where appropriate, before a GLP-1 is prescribed.

That last one surprises people. But it reflects something obesity medicine specialists take seriously: these medications suppress appetite powerfully, and in the wrong patient, that’s a risk rather than a benefit.

“If you have someone that is of normal weight or possibly underweight status, and then you put them on a GLP-1, you can potentially introduce anorexia in that individual,” Dr. Brackett warns. “Someone who is anorexic is much more likely to have a heart attack and far more likely to have cholesterol issues because of that condition.”

A few other situations don’t rule you out automatically, but they do call for extra caution and a real conversation: a history of gallbladder disease, diabetic retinopathy (rapid weight loss can temporarily make it worse), and any history of an eating disorder, which warrants screening before treatment starts.

This is the least glamorous section of any GLP-1 article. It’s also the best single test of whether a provider is legitimate. A prescriber who never asks about your thyroid history, your pancreas, or your pregnancy status isn’t doing you a favor. They’re skipping the part of the job that protects you.

What Doctors Actually Check Before Prescribing

A real GLP-1 evaluation covers five things: your full medical history, your current medications and supplements, your BMI, a contraindication screen, and baseline lab work.

At DrHouse, the labs aren’t optional. Per the platform’s clinical guidelines, every patient starting a GLP-1 receives a lab order at the initial assessment: a comprehensive metabolic panel, complete blood count, thyroid panel, lipid panel, hemoglobin A1C, urinalysis, and a pregnancy test for female patients.

Why so thorough for what people assume is a quick prescription? Because the labs regularly change the plan.

“I’ll see patients with underlying thyroid disease, underlying autoimmune disease, underlying neuroendocrine disease,” Dr. Brackett says of the patients who arrive convinced nothing works for them. “A lot of them haven’t been to the doctor in a long time, but they were willing to come in just to address more of the cosmetic aspect of their weight. And unfortunately we find things that make sense why they’ve been battling or struggling with their weight for so long.”

Read that again if you’ve spent years blaming yourself. Sometimes the reason nothing worked isn’t willpower. It’s an untreated thyroid condition, insulin resistance, or PCOS nobody had checked for. Treating that changes everything, with or without a GLP-1.

Dr. Chandler is blunt about why most people end up in this evaluation in the first place. “Diets help, but patients know, if you were losing weight, I hate to say it, they probably wouldn’t be going for the GLP-1s typically. So obviously what you’ve tried hasn’t worked, so they’re trying something different.”

Your prep for the appointment is refreshingly simple, though. “Really just making sure you know what your height and weight are and your medical history, and that’s really all you need,” Dr. Barry says. “It is important to have an accurate weight, ideally with a scale, so that you’re able to consistently track your weight loss.”

The medication review has teeth too. Combining a GLP-1 with insulin or certain other diabetes drugs can push blood sugar too low, which is exactly the kind of thing a doctor adjusts for before you take a first dose.

And Dr. Brackett pushes every patient to get one more baseline before starting, something smarter than the bathroom scale. “I try to encourage every single one of my patients to seek out a body composition scale to at least get on it just once before they start a GLP-1, just so they already know their baseline lean body mass status,” she says. The point is protecting muscle while the fat comes off. As she puts it: “Muscle is king in terms of life longevity.”

Do You Need a Prescription for GLP-1s? Can You Get Them Without a Doctor?

Yes, you need a prescription. Every FDA-approved GLP-1, including Wegovy, Zepbound, Ozempic, Mounjaro, Rybelsus, and Saxenda, is prescription-only in the United States. There is no legitimate way to get one without a licensed clinician evaluating you first.

Worth saying, because the internet is full of workarounds. “Research peptides” sold with a wink. Gray-market vials from overseas pharmacies. Compounded products of uncertain origin. The FDA has repeatedly warned about unapproved semaglutide products, including dosing errors and unknown ingredients.

The prescription requirement isn’t red tape. It’s the safety mechanism. The contraindication screen, the labs, the medication review, all of it only happens because a clinician has to be involved. Skip the prescription and you skip the screen that catches the thyroid history, the pancreatitis risk, the pregnancy, the eating disorder.

A simple rule of thumb: if a website will sell you a GLP-1 without asking a single question about your health, that’s not a shortcut. That’s the warning sign.

Can a Telehealth Doctor Prescribe GLP-1s? How the Online Process Works

Yes. GLP-1 medications aren’t controlled substances, which means licensed physicians can evaluate you and prescribe them through a telehealth visit in most states. Same BMI thresholds, same contraindication screen, same labs as an in-person visit.

Here’s how weight loss treatment through DrHouse works, per the platform’s clinical protocol:

• Complete your intake. Health history, current medications and supplements, height and weight, and for female patients, pregnancy and breastfeeding status.
• Meet a licensed physician on a video visit. The doctor reviews your history, calculates your BMI, screens for contraindications, and orders your baseline labs.
• If you qualify, your prescription is sent to your pharmacy, starting at the lowest dose of the appropriate medication. If the physician wants more information first, you’ll get lab orders and a follow-up visit instead.
• Follow up monthly. Your physician reviews how you’re tolerating the medication and whether the dose should change. Labs are repeated roughly every six months.

That fourth step matters more than people expect, because dosing isn’t automatic in a physician-led practice. It’s also where a lot of GLP-1 journeys quietly fall apart: research suggests that roughly half of people who start these medications stop within the first year, often over side effects, cost, or simply losing touch with their prescriber. [VERIFY + SOURCE: 2024 adherence analyses, e.g., JAMA Netw Open / Prime Therapeutics claims data] Built-in follow-up is the fix.

“So follow ups, we’re checking your weight to see how much weight you’ve lost over the past month,” Dr. Barry explains. “And then also seeing if there’s any side effects that you’re experiencing that would influence whether we increase or decrease the dose.”

Her dosing philosophy is deliberately unhurried. “I have a more conservative approach. I don’t think you should increase the dose unless the weight loss is slowing. I think it’s better to be conservative and just maximize the effects of the lower doses before you’re increasing, so that you end up with more weight loss overall that way.”

She even has an opinion on how you should weigh yourself between visits. “You don’t want to obsess over the number and daily fluctuations. Ideally, you should just weigh yourself in the morning after you go to the bathroom, just so you have a consistent number to compare your weight loss.”

Ergo Sooru, Co-Founder & CEO, DrHouse: “Weight loss visits work the same way every visit at DrHouse works. A licensed physician looks at your history, orders labs when they’re needed, and decides what’s safe for you. Sometimes that decision is no. That’s not a flaw in telehealth, that’s a doctor doing their job.”

Qualifying Clinically vs. Getting Insurance to Cover It

Here’s the distinction that catches almost everyone off guard. Meeting the FDA’s clinical criteria and meeting your insurance plan’s coverage criteria are two separate hurdles. You can fully qualify for a GLP-1 medically and still have your insurer decline to pay.

Clinically, the bar is the one described above. BMI plus comorbidities, confirmed by a physician. Insurance plans often set a higher one. Many require a documented type 2 diabetes diagnosis, specific comorbidities, prior authorization paperwork, or proof you’ve tried other approaches first.

“The average person who qualifies for GLP-1 tend to be diabetics,” Dr. Brackett says of the coverage landscape. “Sometimes we are lucky, we can get patients to qualify if they have some associated diagnoses, like things like high blood pressure, high cholesterol, post bariatric patients… It truly is dependent on your insurance and whether they’re gonna cover the drug or not.”

Dr. Chandler sees the same split from the visit side. “When we’re going through insurance, there might be more things, requirements that have to be met.” And he’s frank about what drives most of the questions he gets: “The biggest issue is usually cost and access.”

The practical takeaway cuts both ways. Don’t self-reject because you assume coverage is impossible. And don’t assume qualifying clinically guarantees coverage. Your physician can help document the diagnoses that support a prior authorization, which is one more reason those baseline labs matter.

One more detail worth knowing. Wegovy and Zepbound are FDA-approved specifically for chronic weight management. Ozempic, Mounjaro, and Rybelsus are approved for type 2 diabetes, so prescribing them for weight loss is an off-label use. Legal and common, but it changes how insurers treat coverage. A physician can walk you through which is appropriate for your situation.

What If You Don’t Qualify?

If your BMI is below the threshold, a contraindication rules you out, or your labs raise a flag, a good physician doesn’t just say no and hang up. Because “not a GLP-1 candidate” is not the same as “nothing can help.”

Sometimes the evaluation itself is the win. An undiagnosed thyroid condition or insulin resistance found on those baseline labs becomes the real treatment target.

Other times the plan is structured lifestyle change with medical follow-up. DrHouse’s own clinical guidelines pair every GLP-1 plan with a nutritionist referral, a protein target of roughly 25 grams per meal, and at least 150 minutes of moderate exercise per week. That tells you how much weight the protocol puts on the non-medication side, even for patients who do qualify.

Dr. McDaniel, an OB-GYN who is also board-certified in obesity medicine, has watched what that side does to results. “Even with the GLP-1 shots, some people lose weight really slowly because they don’t change their diet. They don’t change how they’re eating. Once they incorporate those changes, they do lose weight at a quicker clip.”

Dr. Barry puts the mechanics simply. “They’re gonna slow down your digestion, they’re gonna make you feel full, and if you combine that with eating nutrient-dense foods that are more full of water and fiber and protein, you’re gonna feel full on smaller amounts of food and you’ll lose more weight with the medication.”

And if you’re close to the threshold but not over it? That’s a conversation, not a dead end. Weight, labs, and health conditions change. A physician who knows your baseline can tell you exactly what would change the answer.

Frequently Asked Questions

Do I Qualify for GLP-1s With a BMI of 27 or 28?

Only if you also have at least one weight-related health condition, such as high blood pressure, high cholesterol, type 2 diabetes, sleep apnea, or PCOS. At a BMI of 30 or above, no comorbidity is required.

Is Prediabetes a Qualifying Condition?

It can be. Prediabetes, generally defined as an A1C of 5.7% or higher, is widely treated as a weight-related comorbidity. An elevated A1C on your baseline labs is exactly the kind of documentation physicians use to support qualification, and insurance prior authorization too.

Can My Primary Care Doctor Prescribe GLP-1 Medication?

Yes. Any licensed physician can prescribe GLP-1s, including primary care doctors and telehealth physicians. Because GLP-1s aren’t controlled substances, the telehealth pathway follows the same criteria as an in-person visit.

What Labs Do I Need Before Starting a GLP-1?

At DrHouse, every patient starting a GLP-1 gets a baseline panel: comprehensive metabolic panel, complete blood count, thyroid panel, lipid panel, hemoglobin A1C, urinalysis, and a pregnancy test for female patients. These labs confirm it’s safe to start and often uncover conditions, like thyroid disease or insulin resistance, that were quietly working against you.

How Much Weight Should I Expect to Lose per Week?

The clinical benchmark is one to two pounds per week. “The package insert says a pound or two per week is what we should be shooting for,” Dr. Chandler says. “So four to eight a month would be success.” Some specialists deliberately aim slower. “You don’t want to be losing so much weight so quickly. You’re really just going to be losing muscle mass at that point,” Dr. Barry cautions. “Slower weight loss is better and more sustainable in the long term.”

Will I Have to Stay on the Medication Forever?

Not necessarily, but stopping is a plan, not an event. “You should taper off of the medication whatever dose you’re on,” Dr. Barry says, and some patients use occasional maintenance doses while they monitor their weight. What actually predicts keeping the weight off is whether the lifestyle changes stick. As Dr. Brackett puts it: “It didn’t take two months to put that weight on. And it certainly is going to take longer than two months to get to the health status that would allow for you to sustain that new weight without the drug.”

Do You Have to Be 18 to Qualify?

For telehealth weight loss treatment, yes. The FDA has approved Wegovy for adolescents 12 and older with obesity, but that path runs through in-person pediatric care. Telehealth platforms, DrHouse included, evaluate adults. [VERIFY: confirm DrHouse 18+ policy wording]

What Are the Most Common Side Effects?

Nausea, vomiting, diarrhea, stomach pain, and constipation, especially in the first weeks as your body adjusts. That’s why treatment starts at the lowest dose and increases gradually, and why your doctor asks about side effects at every follow-up. Persistent symptoms mean the dose holds steady rather than going up.

What’s the Difference Between Wegovy and Ozempic for Qualifying?

They contain the same active ingredient, semaglutide. But Wegovy is FDA-approved for weight management, while Ozempic is approved for type 2 diabetes. The weight loss qualification criteria follow the Wegovy label. Using Ozempic for weight loss is off-label and often harder to get covered.

Talk to a Doctor About It

The fastest way to get a real answer, rather than a chart estimate, is to put your history in front of a physician. You can book a weight loss visit with a licensed doctor at DrHouse, and the doctor makes the final call on whether a GLP-1 is safe and appropriate for you.

Sources

• U.S. Food & Drug Administration. Prescribing Information: Wegovy (semaglutide) injection. accessdata.fda.gov
• U.S. Food & Drug Administration. Prescribing Information: Zepbound (tirzepatide) injection. accessdata.fda.gov
• U.S. Food & Drug Administration. Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss. fda.gov
• Centers for Disease Control and Prevention. Adult Obesity Facts. cdc.gov
• Centers for Disease Control and Prevention. Physical Activity Guidelines for Adults. cdc.gov
• Caleyachetty R, et al. Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study. The Lancet Diabetes & Endocrinology, 2021. doi.org/10.1016/S2213-8587(21)00088-7
• Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine, 2021. doi.org/10.1056/NEJMoa2032183
• Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 2022. doi.org/10.1056/NEJMoa2206038
• World Health Organization. Body mass index (BMI) classification.
• DrHouse Clinical Guidelines for GLP-1 Agonists (internal clinical protocol).
• Physician interviews conducted for the DrHouse “Meet Your Doctor” series: Dr. Christin Barry, Dr. Ragan Brackett, Dr. Chandler, Dr. Sha-Barbara McDaniel.